HNRNPA1P51: A Potential Drug Target Or Biomarker (G729366)

Target Name: HNRNPA1P51

NCBI ID: G729366

HNRNPA1P51

Other Name(s): Heterogeneous nuclear ribonucleoprotein A1 pseudogene 51 | heterogeneous nuclear ribonucleoprotein A1 pseudogene 51

HNRNPA1P51: A Potential Drug Target Or Biomarker

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 51 (HNRNPA1P51) is a gene that has been identified as a potential drug target or biomarker in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

HNRNPA1P51 is a protein that is expressed in various tissues and cells in the body, including the brain, heart, liver, and muscle. It is a member of the heterogeneous nuclear ribonucleoprotein (HNRNA) family, which is a group of proteins that are involved in the regulation of gene expression.

Studies have shown that HNRNPA1P51 is involved in a variety of cellular processes, including cell adhesion, migration, and survival. It has also been shown to play a role in the development and progression of several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key reasons for the potential drug target or biomarker status of HNRNPA1P51 is its involvement in several diseases that have a high impact on human health and wellbeing. For example, HNRNPA1P51 has been shown to be involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

In addition, HNRNPA1P51 has also been shown to be involved in the development and progression of cancer, including breast cancer and colorectal cancer. This suggests that it may be a useful target for cancer therapies.

Another potential reason for the potential drug target or biomarker status of HNRNPA1P51 is its expression in various tissues and cells in the body, which suggests that it may be a useful biomarker for tracking disease progression and treatment response.

In conclusion, HNRNPA1P51 is a gene that has been identified as a potential drug target or biomarker in a variety of diseases. Its involvement in cellular processes and its expression in various tissues and cells make it a promising target for further research and development. Further studies are needed to fully understand its potential as a drug target or biomarker.

Protein Name: Heterogeneous Nuclear Ribonucleoprotein A1 Pseudogene 51

The "HNRNPA1P51 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HNRNPA1P51 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets